Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 61 | 2025 | 2535 | 7.190 |
Why?
|
| Homosexuality, Male | 28 | 2025 | 483 | 5.340 |
Why?
|
| Prisoners | 16 | 2025 | 95 | 5.310 |
Why?
|
| Sexually Transmitted Diseases | 12 | 2025 | 172 | 3.460 |
Why?
|
| Sexual Behavior | 22 | 2025 | 634 | 2.930 |
Why?
|
| Substance-Related Disorders | 10 | 2025 | 825 | 2.910 |
Why?
|
| Anti-HIV Agents | 10 | 2023 | 475 | 2.760 |
Why?
|
| Bisexuality | 9 | 2018 | 210 | 1.920 |
Why?
|
| Continuity of Patient Care | 6 | 2022 | 118 | 1.840 |
Why?
|
| Sexual Partners | 13 | 2022 | 325 | 1.730 |
Why?
|
| Los Angeles | 25 | 2025 | 390 | 1.650 |
Why?
|
| Prisons | 11 | 2020 | 51 | 1.490 |
Why?
|
| Male | 65 | 2025 | 22779 | 1.350 |
Why?
|
| Risk-Taking | 12 | 2022 | 456 | 1.310 |
Why?
|
| Humans | 84 | 2025 | 42163 | 1.240 |
Why?
|
| Condoms | 9 | 2018 | 148 | 1.210 |
Why?
|
| Adult | 48 | 2025 | 13458 | 1.130 |
Why?
|
| Unsafe Sex | 7 | 2020 | 162 | 1.120 |
Why?
|
| Peer Group | 4 | 2025 | 173 | 1.000 |
Why?
|
| Female | 43 | 2025 | 24018 | 0.880 |
Why?
|
| United States | 23 | 2024 | 5072 | 0.860 |
Why?
|
| Siblings | 1 | 2023 | 22 | 0.820 |
Why?
|
| Middle Aged | 31 | 2025 | 11819 | 0.820 |
Why?
|
| Central Nervous System Stimulants | 2 | 2022 | 181 | 0.800 |
Why?
|
| Safe Sex | 5 | 2018 | 78 | 0.790 |
Why?
|
| Criminals | 3 | 2020 | 18 | 0.780 |
Why?
|
| Income Tax | 1 | 2022 | 2 | 0.770 |
Why?
|
| Psychiatry | 1 | 2022 | 35 | 0.750 |
Why?
|
| HIV Seropositivity | 4 | 2014 | 196 | 0.690 |
Why?
|
| Cannabis | 1 | 2023 | 90 | 0.690 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 959 | 0.670 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2020 | 11 | 0.670 |
Why?
|
| Transsexualism | 2 | 2010 | 20 | 0.640 |
Why?
|
| Patient Participation | 1 | 2020 | 87 | 0.630 |
Why?
|
| Risk Reduction Behavior | 3 | 2022 | 137 | 0.630 |
Why?
|
| Patient Selection | 1 | 2020 | 192 | 0.600 |
Why?
|
| Trust | 1 | 2020 | 157 | 0.600 |
Why?
|
| Young Adult | 15 | 2025 | 4936 | 0.590 |
Why?
|
| Heterosexuality | 2 | 2011 | 96 | 0.580 |
Why?
|
| Minority Groups | 2 | 2020 | 663 | 0.520 |
Why?
|
| Behavior Therapy | 2 | 2018 | 179 | 0.490 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 680 | 0.480 |
Why?
|
| Crime | 2 | 2020 | 29 | 0.470 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 471 | 0.460 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 309 | 0.440 |
Why?
|
| HIV Seroprevalence | 3 | 2004 | 11 | 0.440 |
Why?
|
| Social Identification | 2 | 2016 | 63 | 0.430 |
Why?
|
| HIV | 4 | 2022 | 100 | 0.390 |
Why?
|
| Interviews as Topic | 3 | 2024 | 428 | 0.390 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 188 | 0.390 |
Why?
|
| Adolescent | 15 | 2022 | 5950 | 0.390 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 410 | 0.380 |
Why?
|
| California | 6 | 2024 | 531 | 0.380 |
Why?
|
| Social Support | 5 | 2025 | 438 | 0.360 |
Why?
|
| Medicaid | 2 | 2024 | 138 | 0.360 |
Why?
|
| Prejudice | 2 | 2009 | 116 | 0.350 |
Why?
|
| Income | 3 | 2022 | 160 | 0.340 |
Why?
|
| Qualitative Research | 3 | 2024 | 526 | 0.340 |
Why?
|
| Gender Identity | 3 | 2021 | 117 | 0.330 |
Why?
|
| Anti-Retroviral Agents | 2 | 2022 | 158 | 0.330 |
Why?
|
| Terminology as Topic | 1 | 2010 | 40 | 0.320 |
Why?
|
| Prevalence | 9 | 2017 | 1597 | 0.310 |
Why?
|
| Preventive Health Services | 1 | 2009 | 65 | 0.300 |
Why?
|
| Health Status Disparities | 3 | 2012 | 705 | 0.300 |
Why?
|
| Truth Disclosure | 2 | 2012 | 26 | 0.270 |
Why?
|
| Aged | 9 | 2023 | 7982 | 0.270 |
Why?
|
| Health Surveys | 2 | 2011 | 401 | 0.270 |
Why?
|
| Self Concept | 1 | 2008 | 170 | 0.270 |
Why?
|
| Logistic Models | 5 | 2020 | 1001 | 0.260 |
Why?
|
| Research | 1 | 2008 | 177 | 0.250 |
Why?
|
| Risk Factors | 11 | 2018 | 3942 | 0.240 |
Why?
|
| Age Factors | 4 | 2018 | 1139 | 0.240 |
Why?
|
| Attitude | 1 | 2006 | 108 | 0.230 |
Why?
|
| Naloxone | 1 | 2024 | 56 | 0.220 |
Why?
|
| Allostasis | 2 | 2017 | 22 | 0.220 |
Why?
|
| Narcotic Antagonists | 1 | 2024 | 78 | 0.220 |
Why?
|
| Mass Screening | 4 | 2020 | 531 | 0.220 |
Why?
|
| Health Promotion | 2 | 2022 | 691 | 0.220 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 73 | 0.220 |
Why?
|
| Criminal Law | 2 | 2021 | 28 | 0.220 |
Why?
|
| Ambulatory Care Facilities | 1 | 2004 | 65 | 0.220 |
Why?
|
| Ambulatory Care | 1 | 2024 | 81 | 0.210 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 573 | 0.200 |
Why?
|
| Health Expenditures | 1 | 2023 | 44 | 0.200 |
Why?
|
| Beauty Culture | 1 | 2022 | 2 | 0.200 |
Why?
|
| Incidence | 3 | 2022 | 1054 | 0.190 |
Why?
|
| Methamphetamine | 2 | 2022 | 167 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2023 | 238 | 0.190 |
Why?
|
| Focus Groups | 3 | 2018 | 398 | 0.190 |
Why?
|
| Emigration and Immigration | 1 | 2002 | 85 | 0.190 |
Why?
|
| Illinois | 4 | 2024 | 11 | 0.190 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 74 | 0.180 |
Why?
|
| Opioid-Related Disorders | 1 | 2024 | 188 | 0.180 |
Why?
|
| RNA, Viral | 4 | 2018 | 317 | 0.170 |
Why?
|
| Medicare | 1 | 2023 | 326 | 0.170 |
Why?
|
| Mental Health | 2 | 2022 | 363 | 0.160 |
Why?
|
| Sexuality | 2 | 2018 | 56 | 0.160 |
Why?
|
| Disease Transmission, Infectious | 1 | 2019 | 30 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2017 | 98 | 0.150 |
Why?
|
| HIV-1 | 4 | 2014 | 747 | 0.150 |
Why?
|
| Coitus | 2 | 2016 | 12 | 0.140 |
Why?
|
| Case Management | 1 | 2018 | 24 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2019 | 225 | 0.140 |
Why?
|
| Medication Adherence | 1 | 2020 | 177 | 0.140 |
Why?
|
| Mortality | 2 | 2017 | 174 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1058 | 0.140 |
Why?
|
| Personal Autonomy | 1 | 2017 | 21 | 0.140 |
Why?
|
| Residence Characteristics | 1 | 2020 | 359 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 56 | 0.130 |
Why?
|
| Disease Management | 1 | 2017 | 68 | 0.130 |
Why?
|
| Chicago | 4 | 2020 | 30 | 0.130 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 154 | 0.130 |
Why?
|
| Sex Factors | 2 | 2011 | 1008 | 0.130 |
Why?
|
| Religion | 1 | 2017 | 90 | 0.130 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 1221 | 0.130 |
Why?
|
| Unemployment | 1 | 2016 | 27 | 0.120 |
Why?
|
| Community Health Services | 1 | 2017 | 207 | 0.120 |
Why?
|
| Professional-Patient Relations | 1 | 2015 | 60 | 0.120 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 3077 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 1051 | 0.110 |
Why?
|
| Self Efficacy | 1 | 2016 | 211 | 0.110 |
Why?
|
| Counseling | 2 | 2018 | 134 | 0.110 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 216 | 0.110 |
Why?
|
| Time Factors | 4 | 2017 | 1848 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2015 | 336 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2013 | 358 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 729 | 0.090 |
Why?
|
| Community-Acquired Infections | 1 | 2010 | 22 | 0.080 |
Why?
|
| Hierarchy, Social | 1 | 2010 | 9 | 0.080 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 62 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 65 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2010 | 169 | 0.080 |
Why?
|
| Stress, Psychological | 2 | 2012 | 641 | 0.080 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 1 | 2009 | 7 | 0.080 |
Why?
|
| History, 17th Century | 1 | 2009 | 5 | 0.080 |
Why?
|
| History, 18th Century | 1 | 2009 | 7 | 0.080 |
Why?
|
| Viral Load | 3 | 2022 | 344 | 0.080 |
Why?
|
| Contact Tracing | 1 | 2009 | 22 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2009 | 26 | 0.080 |
Why?
|
| Culture | 1 | 2010 | 172 | 0.080 |
Why?
|
| Internal-External Control | 1 | 2009 | 60 | 0.070 |
Why?
|
| Demography | 1 | 2009 | 195 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 124 | 0.070 |
Why?
|
| Urban Population | 2 | 2016 | 364 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2012 | 377 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 2803 | 0.070 |
Why?
|
| Community Networks | 1 | 2009 | 106 | 0.070 |
Why?
|
| Philadelphia | 2 | 2018 | 20 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2009 | 141 | 0.070 |
Why?
|
| Cultural Competency | 1 | 2009 | 137 | 0.070 |
Why?
|
| Health Behavior | 1 | 2012 | 568 | 0.070 |
Why?
|
| HIV Antibodies | 2 | 2004 | 24 | 0.060 |
Why?
|
| Decision Making | 1 | 2009 | 242 | 0.060 |
Why?
|
| Age Distribution | 2 | 2003 | 249 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2020 | 1729 | 0.060 |
Why?
|
| Anonymous Testing | 1 | 2004 | 1 | 0.060 |
Why?
|
| Washington | 1 | 2004 | 36 | 0.060 |
Why?
|
| Motivation | 1 | 2008 | 492 | 0.060 |
Why?
|
| Southwestern United States | 1 | 2004 | 47 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2023 | 61 | 0.050 |
Why?
|
| Marital Status | 1 | 2003 | 46 | 0.050 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2004 | 128 | 0.050 |
Why?
|
| Depression | 2 | 2023 | 837 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 1999 | 72 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2003 | 587 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 1999 | 181 | 0.040 |
Why?
|
| Texas | 1 | 2022 | 428 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 136 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 1997 | 244 | 0.040 |
Why?
|
| Water Pollution | 1 | 1999 | 13 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1999 | 11 | 0.040 |
Why?
|
| Swimming | 1 | 1999 | 40 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 1997 | 112 | 0.040 |
Why?
|
| Water Microbiology | 1 | 1999 | 82 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2019 | 190 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 311 | 0.040 |
Why?
|
| Pregnancy | 3 | 1999 | 1737 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2018 | 1574 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 602 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 245 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2014 | 884 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2014 | 295 | 0.030 |
Why?
|
| Cocaine | 1 | 2019 | 248 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 183 | 0.030 |
Why?
|
| Child | 1 | 2004 | 3381 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 512 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 68 | 0.030 |
Why?
|
| Intention | 1 | 2016 | 103 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 725 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 1586 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 850 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 10 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 508 | 0.030 |
Why?
|
| Immunoassay | 1 | 2014 | 69 | 0.030 |
Why?
|
| Urban Health | 1 | 2013 | 99 | 0.030 |
Why?
|
| Emotions | 1 | 2016 | 251 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 176 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2010 | 1266 | 0.020 |
Why?
|
| Behavior | 1 | 2010 | 34 | 0.020 |
Why?
|
| Carrier State | 1 | 2010 | 33 | 0.020 |
Why?
|
| HIV Core Protein p24 | 2 | 2001 | 11 | 0.020 |
Why?
|
| San Francisco | 1 | 2010 | 34 | 0.020 |
Why?
|
| Alcoholism | 1 | 2013 | 292 | 0.020 |
Why?
|
| Social Class | 1 | 2012 | 286 | 0.020 |
Why?
|
| beta 2-Microglobulin | 2 | 1999 | 10 | 0.020 |
Why?
|
| Neopterin | 2 | 1999 | 13 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 733 | 0.020 |
Why?
|
| Health Policy | 1 | 2009 | 184 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1997 | 91 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 1999 | 276 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 1999 | 379 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2003 | 224 | 0.010 |
Why?
|
| Educational Status | 1 | 2003 | 335 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2001 | 27 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 111 | 0.010 |
Why?
|
| Oceans and Seas | 1 | 1999 | 17 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1999 | 30 | 0.010 |
Why?
|
| Sewage | 1 | 1999 | 27 | 0.010 |
Why?
|
| Enterobacteriaceae | 1 | 1999 | 29 | 0.010 |
Why?
|
| Leisure Activities | 1 | 1999 | 38 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1997 | 57 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1997 | 122 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1997 | 200 | 0.010 |
Why?
|
| Postpartum Period | 1 | 1997 | 91 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1997 | 960 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 774 | 0.010 |
Why?
|
| Infant | 1 | 1997 | 1143 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1997 | 2485 | 0.010 |
Why?
|